We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (APRHAI) provides practical and scientific advice to the government on minimising the risk of healthcare associated infections.
Annual summary of activities carried out by the Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infections (APRHAI).
AMRHAI (antimicrobial resistance and healthcare associated infections) is the national reference unit for investigating AMR in healthcare-associated bacteria.
For all independent prescribers to help improve the quality of prescribing practice.
Outlines a more focused, cost-effective approach to MRSA screening whilst concentrating on reducing infections and improving patient health.
Measures to assess trends in antimicrobial resistance and track progress.
This toolkit provides an outline of evidence-based antimicrobial stewardship in inpatient care settings.
European Antibiotic Awareness Day is a public health initiative aimed at encouraging responsible use responsible use of antibiotics.
Posters, leaflet, case studies and other resources to support local events for European Antibiotic Awareness Day 2013.
Prescriber checklist, web banner and poster to support local secondary care events for European Antibiotic Awareness Day 2013.
The management, surveillance and epidemiology of carbapenem resistance.
Findings from a 2021 to 2022 incident response by the UK Health Security Agency (UKHSA) to Staphylococcus capitis in UK neonatal units.
This consultation asks for comments in relation to UK SMI B 41: investigation of urine.
The third annual progress report on the UK 5-year antimicrobial resistance (AMR) strategy, including future plans.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.